CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $588,195
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Dillione Janet Director | Exercise or conversion | +48,909 | 117,835 | ||
| 2026-09-18 | Dillione Janet Director | Exercise or conversion · Phantom Stock | −48,909 | 0 | ||
| 2026-01-26 | Dillione Janet Director | Grant or award | +30,453 | 68,926 | ||
| 2026-01-21 | Dillione Janet Director | Sale 10b5-1 | −10,000 | $6.88 | $69K | 38,473 |
| 2025-12-09 | Dillione Janet Director | Exercise or conversion 10b5-1 | +19,000 | $9.55 | $181K | 67,473 |
| 2025-12-09 | Dillione Janet Director | Exercise or conversion 10b5-1 | +15,000 | $5.63 | $84K | 82,473 |
| 2025-12-09 | Dillione Janet Director | Sale 10b5-1 | −34,000 | $12.00 | $408K | 48,473 |
| 2025-12-09 | Dillione Janet Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −19,000 | 0 | ||
| 2025-12-09 | Dillione Janet Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −15,000 | 0 | ||
| 2025-12-02 | Dillione Janet Director | Exercise or conversion 10b5-1 | +12,210 | $4.03 | $49K | 60,683 |
| 2025-12-02 | Dillione Janet Director | Exercise or conversion 10b5-1 | +15,124 | $4.43 | $67K | 75,807 |
| 2025-12-02 | Dillione Janet Director | Exercise or conversion 10b5-1 | +19,323 | $3.55 | $69K | 95,130 |
| 2025-12-02 | Dillione Janet Director | Sale 10b5-1 | −46,657 | $10.00 | $467K | 48,473 |
| 2025-12-02 | Dillione Janet Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −12,210 | 0 | ||
| 2025-12-02 | Dillione Janet Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −15,124 | 0 | ||
| 2025-12-02 | Dillione Janet Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) 10b5-1 | −19,323 | 5,000 | ||
| 2025-11-24 | Dillione Janet Director | Exercise or conversion | +8,000 | $2.85 | $23K | 56,473 |
| 2025-11-24 | Dillione Janet Director | Exercise or conversion | +7,790 | $4.03 | $31K | 64,263 |
| 2025-11-24 | Dillione Janet Director | Exercise or conversion | +4,876 | $4.43 | $22K | 69,139 |
| 2025-11-24 | Dillione Janet Director | Exercise or conversion | +5,677 | $3.55 | $20K | 74,816 |
Page 1 of 4 · 69 trades